相关实验视频

Updated: May 28, 2025

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

在耐药结核病患者的QT间隔评估中开发和验证可变时间校正因子

Thanakorn Vongjarudech¹, Anne-Gaëlle Dosne², Bart Remmerie²

¹Department of Pharmacy, Uppsala University, Uppsala, Sweden.

International journal of antimicrobial agents

|February 8, 2025

概括

一个新的时间变化的校正因子 (CF) 准确地调整结核病 (TB) 患者的QT间隔,因为他们的心率 (HR) 在治疗期间正常化. 这种方法可以防止QT延长的错误诊断,并改善结核病临床试验中的药物评估.

科学领域:

心脏病学心脏病学
药理学药理学是指药理学的学科.
传染性疾病传染性疾病

背景情况:

慢心跳是活跃结核病 (TB) 的常见症状,通常会在治疗后消失.
在结核病治疗期间心率 (HR) 发生变化时,标准QT校正因数 (CF) 可能不准确.
现有的方法很难解释结核病患者的动态QT-HR关系.

研究的目的:

开发和验证肺结核患者QT间隔的时间变化校正因数 (CF).
在结核病治疗期间提高QT间隔评估的准确性.
为了减轻误诊QT延长的风险,并指导治疗决策.

主要方法:

开发了一个心率 (HR) 正常化模型,包括治疗时间,昼夜节律,药物代谢物和患者共变量.
根据治疗期间估计的HR变化率构建了一个时间变化的CF.
通过使用线性回归来评估正确的QT (QTc) 与HR的独立性来评估CF表现.

主要成果:

时间变化的CF在7.74周内从0.4081降至0.33.
线性回归分析显示,QTc与时间之间没有显著的斜率或截止,表明HR校正成功.
该模型准确地捕捉了整个结核病治疗过程中的动态QT-HR关系.

结论:

时间变化的CF有效地纠正了正在接受治疗的结核病患者的QT间隔.
这种方法减少了误解QT延长的可能性,有助于更安全的药物评估.
改进的QT间隔评估支持更好的治疗策略和结核病患者的临床试验结果.

关键词:

调整因子是指调整因子.心率的心率是什么心率是什么心率在 QT 间隔.这是一种QT延长.快速心跳是什么意思快速心跳是什么意思结核病是一种疾病.

更多相关视频

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples

Published on: May 19, 2020

相关概念视频

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...